Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis
- 1 April 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 13 (2) , 141-147
- https://doi.org/10.1097/00041433-200204000-00005
Abstract
Cytoplasmic fatty acid-binding proteins (FABPs) are a family of proteins, expressed in a tissue-specific manner, that bind fatty acid ligands and are involved in shuttling fatty acids to cellular compartments, modulating intracellular lipid metabolism, and regulating gene expression. Several members of the FABP family have been shown to have important roles in regulating metabolism and have links to the development of insulin resistance and the metabolic syndrome. Recent studies demonstrate a role for intestinal FABP in the control of dietary fatty acid absorption and chylomicron secretion. Heart FABP is essential for normal myocardial fatty acid oxidation and modulates fatty acid uptake in skeletal muscle. Liver FABP is directly involved in fatty acid ligand signaling to the nucleus and interacts with peroxisome proliferator-activated receptors in hepatocytes. The adipocyte FABP (aP2) has been shown to affect insulin sensitivity, lipid metabolism and lipolysis, and has recently been shown to play an important role in atherosclerosis. Interestingly, expression of aP2 by the macrophage promotes atherogenesis, thus providing a link between insulin resistance, intracellular fatty acid disposition, and foam cell formation. The FABPs are promising targets for the treatment of dyslipidemia, insulin resistance, and atherosclerosis in humans.Keywords
This publication has 39 references indexed in Scilit:
- FABP2 genotype is associated with insulin sensitivity in older womenMetabolism, 2001
- Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid–Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring StudyDiabetes Care, 2001
- Fatty acid binding protein 2 and insulin resistanceEuropean Journal of Clinical Investigation, 2001
- Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean menMetabolism, 2001
- Characterization of a New Member of the Fatty Acid-binding Protein Family That Binds All-trans-retinolJournal of Biological Chemistry, 2001
- Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participantsAtherosclerosis, 2000
- Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2000
- The fatty acid transport function of fatty acid-binding proteinsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Physiological properties and functions of intracellular fatty acid-binding proteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.Journal of Clinical Investigation, 1995